The historical rank and industry rank for Frontier Biotechnologies's OCF Margin % or its related term are showing as below:
SHSE:688221'
s OCF Margin % Range Over the Past 10 Years
Min: -4140.97 Med: -287.47 Max: 164.37
Current: 10.19
During the past 12 years, the highest OCF Margin % of Frontier Biotechnologies was 164.37%. The lowest was -4140.97%. And the median was -287.47%.
SHSE:688221's OCF Margin % is ranked better than 50.89% of 957
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs SHSE:688221: 10.19
Frontier Biotechnologies OCF Margin % Related Terms
Frontier Biotechnologies OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Frontier Biotechnologies's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Frontier Biotechnologies OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Frontier Biotechnologies's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Frontier Biotechnologies's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Frontier Biotechnologies (SHSE:688221) has a OCF Margin % of 73.33% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Frontier Biotechnologies and its competitors. According to the industry distribution chart, Frontier Biotechnologies ranks #470 out of 957 companies in the Drug Manufacturers industry, placing it in the top 49.1%.
Is Frontier Biotechnologies' OCF Margin % too high?
Frontier Biotechnologies' current OCF Margin % is 73.33%. The Drug Manufacturers industry median OCF Margin % is 9.95. Frontier Biotechnologies' value of 73.33% is 637% above this industry median. Based on the distribution chart, Frontier Biotechnologies ranks #470 out of 957 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Frontier Biotechnologies has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Frontier Biotechnologies' OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Frontier Biotechnologies ranks #470 out of 957 companies for OCF Margin %. This puts Frontier Biotechnologies in the upper half of its industry. The industry median OCF Margin % is 9.95. Frontier Biotechnologies' value of 73.33% is 637% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Frontier Biotechnologies's current OCF Margin % of 73.33% is 637% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Frontier Biotechnologies and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Frontier Biotechnologies's current OCF Margin % is 73.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Frontier Biotechnologies stock overvalued right now?
Based on GuruFocus' analysis, Frontier Biotechnologies (SHSE:688221) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥37.25, compared to a current price of ¥26.63 — trading 28.5% below its estimated fair value. The current OCF Margin % is 73.33% and 637% above the Drug Manufacturers industry median of 9.95. Frontier Biotechnologies' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Frontier Biotechnologies (SHSE:688221), the current OCF Margin % is 73.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Frontier Biotechnologies (SHSE:688221) Overvalued in 2026?
Based on GuruFocus' analysis, Frontier Biotechnologies stock appears to be undervalued.
The current stock price of ¥26.63 is trading 28.5% below its estimated GF Value™ of ¥37.25.
GuruFocus considers Frontier Biotechnologies to be Modestly Undervalued.
Key valuation signals for SHSE:688221:
OCF Margin %: 73.33%
GF Value™: ¥37.25 vs. price of ¥26.63 (28.5% below fair value)
Industry Position: 637% above the Drug Manufacturers median (#470 of 957)
No single metric tells the full story. See the SHSE:688221 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688221 has been successfully added to your 
